Amgen Inc at Citi Global Healthcare Conference Transcript
(audio in progress) We're thrilled to have Amgen with us today.
We have a couple of folks here. We have Peter Griffith, EVP and CFO. We have Kave Niksefat, Senior VP, Global Marketing and Access; and then, Casey Capparelli from the IR team.
Guys, welcome. Thanks for joining us.
Thank you, Geoff. Thanks for having us.
Questions & Answers
Peter, we'll start off with you, just with respect to the trends this year. You've had some standouts. It doesn't look like the denosumab headwinds were as bad as people originally thought. It looks like Repatha is still growing very nicely.
How do you look at the momentum going into '26, on the back of (inaudible) these trends extrapolatable to '26?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
